Efficacy of high-dose chemotherapy combined with hematopoietic stem cell transplantation in advanced neuroblastoma.

Front Oncol · 2026 · PMC13215894 · PMID 42222419

Europe PMC DOI

hedged sentence

0.0790

closest p · 1.6× alpha

0.0790

boldest claim

The sentences

did not reach statistical significanceP = 0.079so close (0.05 < p ≤ 0.1)

3.5 Safety outcomes During consolidation, grade 3–4 neutropenia was frequent in both groups (91.7% in the HDC group vs 96.1% in the HDC+HSCT group; P = 0.179), and rates of grade 3–4 thrombocytopenia and anemia were numerically higher in the HDC+HSCT group but did not reach statistical significance (P = 0.079 and P = 0.204, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.